CALL/MERCK & CO./140/0.1/17.01.25 Stock

Warrant

DE000GZ9BGC4

Real-time BOERSE MUENCHEN 06:26:42 2024-07-05 am EDT
0.258 EUR -5.15% Intraday chart for CALL/MERCK & CO./140/0.1/17.01.25
Current month-28.42%
1 month-33.82%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 0.258 -5.15%
24-07-04 0.272 -1.81%
24-07-03 0.277 -16.31%
24-07-02 0.331 -7.02%
24-07-01 0.356 -6.32%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 06:26 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Goldman Sachs
WKN GZ9BGC
ISINDE000GZ9BGC4
Date issued 2023-02-27
Strike 140 $
Maturity 2025-01-17 (197 Days)
Parity 10 : 1
Emission price 0.45
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.703
Lowest since issue 0.058
Spread 0.03
Spread %10.34%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.8 USD
Average target price
142.7 USD
Spread / Average Target
+13.37%
Consensus